Letter to the editor concerning the article: “Potential Cerebrovascular
Accident Signal for Risankizumab: A Disproportionality Analysis of the
FDA Adverse Event Reporting System (FAERS)”
- Ranjeeta Sinvhal,
- Whitney Krueger,
- Ryan Kilpatrick,
- Danielle Coppola
01 Mar 2023Submitted to British Journal of Clinical Pharmacology 06 Mar 2023Submission Checks Completed
06 Mar 2023Assigned to Editor
27 Mar 2023Reviewer(s) Assigned
01 Apr 2023Review(s) Completed, Editorial Evaluation Pending
03 Apr 2023Editorial Decision: Accept
